Category: Portfolio news
Announcing XinThera’s Acquisition by Gilead Sciences
Today we are pleased to share the news that XinThera has been acquired by Gilead Sciences. XinThera was founded in 2021 by Stephen Kaldor, Qing Dong, and Gene Hung, all serial entrepreneurs we have worked…
Thoughts on the Affinivax Acquisition
We were very excited today when GSK announced their acquisition of our portfolio company Affinivax. This is a great move to advance their vaccines that combat novel and resistant infectious diseases that currently have no…
